Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viqar Syed

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Molecular Cancer Research : MCR|September 22, 2011
Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3FHuyen Nguyen, Vessela S Ivanova, Leyla Kavandi, et al.
Molecules (Basel, Switzerland)|November 11, 2025
RETRACTED: Waheed et al. Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A. <i>Molecules</i> 2019, <i>24</i>, 3722Sana Waheed, Robert Ys Cheng, Yovanni Casablanca, et al.
Molecules (Basel, Switzerland)|October 19, 2019
Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1ASana Waheed, Robert Ys Cheng, Yovanni Casablanca, et al.
Oncotarget|July 30, 2025
Retraction: Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMPSana Waheed, Batsukh Dorjbal, Chad A Hamilton, et al.
Oncotarget|January 27, 2018
Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMPSana Waheed, Batsukh Dorjbal, Chad A Hamilton, et al.
Biochemical and Biophysical Research Communications|July 8, 2008
Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cellsPaul Mak, Meena Jaggi, Viqar Syed, et al.
Biomedicines|July 2, 2025
RETRACTED: Paucarmayta et al. Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro. <i>Biomedicines</i> 2020, <i>8</i>, 73Ana Paucarmayta, Hannah Taitz, Latoya McGlorthan, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 21, 2018
A Cell Line-based Immunohistochemical p53 Expression Pattern Control PanelImran Hussain, Robin S Howard, Viqar Syed, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 5, 2011
Surveillance of AF recurrence post-surgical AF ablation using implantable cardiac monitorJohn H Ip, Maria Viqar-Syed, Denise Grimes, et al.
Biomedicines|April 5, 2020
Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In VitroAna Paucarmayta, Hannah Taitz, Latoya McGlorthan, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Molecular Cancer Research : MCR|September 22, 2011
Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3FHuyen Nguyen, Vessela S Ivanova, Leyla Kavandi, et al.
Molecules (Basel, Switzerland)|November 11, 2025
RETRACTED: Waheed et al. Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A. <i>Molecules</i> 2019, <i>24</i>, 3722Sana Waheed, Robert Ys Cheng, Yovanni Casablanca, et al.
Molecules (Basel, Switzerland)|October 19, 2019
Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1ASana Waheed, Robert Ys Cheng, Yovanni Casablanca, et al.
Oncotarget|July 30, 2025
Retraction: Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMPSana Waheed, Batsukh Dorjbal, Chad A Hamilton, et al.
Oncotarget|January 27, 2018
Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMPSana Waheed, Batsukh Dorjbal, Chad A Hamilton, et al.
Biochemical and Biophysical Research Communications|July 8, 2008
Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cellsPaul Mak, Meena Jaggi, Viqar Syed, et al.
Biomedicines|July 2, 2025
RETRACTED: Paucarmayta et al. Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro. <i>Biomedicines</i> 2020, <i>8</i>, 73Ana Paucarmayta, Hannah Taitz, Latoya McGlorthan, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 21, 2018
A Cell Line-based Immunohistochemical p53 Expression Pattern Control PanelImran Hussain, Robin S Howard, Viqar Syed, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 5, 2011
Surveillance of AF recurrence post-surgical AF ablation using implantable cardiac monitorJohn H Ip, Maria Viqar-Syed, Denise Grimes, et al.
Biomedicines|April 5, 2020
Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In VitroAna Paucarmayta, Hannah Taitz, Latoya McGlorthan, et al.
Pageof 5